Biotech Stocks AMRX, BLSM, NEOG Hit 52-Week Highs on Clinical, Earnings Catalysts

Three biotech stocks — Amneal Pharmaceuticals (AMRX), Bellerophon Therapeutics (BLSM) and Neogen Corp. (NEOG) — reached 52-week highs on September 22, 2026, lifted by company-specific catalysts including positive quarterly results and clinical trial data. The gains reflect selective investor appetite within the sector, where individual catalysts are driving outsized moves rather than broad-based buying. No specific figures for the quarterly reports or trial results were disclosed. The three names now trade at their highest levels in the past year.